Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for sleep after pediatric TBI
NCT04932096Phase 2Completed
- Sponsor
- Oregon Health & Science University
- Start
- Jan 2023
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in traumatic brain injury (TBI), sponsored by Oregon Health & Science University. Started Jan 2023; status: completed.
02
Drugs
melatonin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT04932096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04932096.